|
Endothelium/vascular type/nitric oxide
Citations 241-250 of 1327 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Tumor Necrosis Factor- Induces Endothelial Dysfunction in Leprdb Mice
- Xue Gao, Souad Belmadani, Andrea Picchi, Xiangbin Xu, Barry J. Potter, Neera Tewari-Singh, Stefano Capobianco, William M. Chilian, and Cuihua Zhang
Circulation published January 2, 2007, doi:10.1161/CIRCULATIONAHA.106.650671
[Abstract]
- Heart Failure
Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure
- Gregory D. Lewis, Justine Lachmann, Janice Camuso, John J. Lepore, Jordan Shin, Maryann E. Martinovic, David M. Systrom, Kenneth D. Bloch, and Marc J. Semigran
Circulation 2007;115:59-66; published online before print as doi:10.1161/CIRCULATIONAHA.106.626226
[Abstract]
[Full text]
- Heart Failure
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation 2007;115:67-75; published online before print as doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
[Full text]
- Articles
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2850-2870, doi:10.1161/CIRCULATIONAHA.106.655688
[Full text]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2871-2891, doi:10.1161/CIRCULATIONAHA.106.655761
[Full text]
- Articles
Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure
- Gregory D. Lewis, Justine Lachmann, Janice Camuso, John J. Lepore, Jordan Shin, Maryann E. Martinovic, David M. Systrom, Kenneth D. Bloch, and Marc J. Semigran
Circulation published December 18, 2006, doi:10.1161/CIRCULATIONAHA.106.626226
[Abstract]
- Molecular Cardiology
Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo
- Wei Sun, Tzong-Shyuan Lee, Minjia Zhu, Chunang Gu, Yinsheng Wang, Yi Zhu, and John Y-J. Shyy
Circulation 2006;114:2655-2662; published online before print as doi:10.1161/CIRCULATIONAHA.106.630194
[Abstract]
[Full text]
- Vascular Medicine
Improvement of Peripheral Endothelial Dysfunction by Protein Tyrosine Phosphatase Inhibitors in Heart Failure
- Magali Vercauteren, Elise Remy, Corinne Devaux, Brigitte Dautreaux, Jean-Paul Henry, Fabrice Bauer, Paul Mulder, Rob Hooft van Huijsduijnen, Agnès Bombrun, Christian Thuillez, and Vincent Richard
Circulation 2006;114:2498-2507; published online before print as doi:10.1161/CIRCULATIONAHA.106.630129
[Abstract]
[Full text]
- Vascular Medicine
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
- Jacob George, Elaine Carr, Justine Davies, J.J.F. Belch, and Allan Struthers
Circulation 2006;114:2508-2516; published online before print as doi:10.1161/CIRCULATIONAHA.106.651117
[Abstract]
[Full text]
|
|
